ripekg:evaluation/RIPEA61C486302F135B42 |
prov:used |
ripekg:registry-evidence/RIPEA61C486302F135B42 |
ripekg:registry-evidence/RIPEA61C486302F135B42 |
rdf:type |
rdfs:Resource |
ripekg:registry-evidence/RIPEA61C486302F135B42 |
rdf:type |
owl:Thing |
ripekg:registry-evidence/RIPEA61C486302F135B42 |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:registry-evidence/RIPEA61C486302F135B42 |
rdf:type |
ripe:RegistryEvidenceRegistry evidence |
ripekg:registry-evidence/RIPEA61C486302F135B42 |
rdf:type |
tido:Evidence |
ripekg:registry-evidence/RIPEA61C486302F135B42 |
prov:wasAttributedTo |
ripekg:source/clinicaltrials-govClinicalTrials.gov |
ripekg:registry-evidence/RIPEA61C486302F135B42 |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA61C486302F135B42 |
ripekg:registry-evidence/RIPEA61C486302F135B42 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA61C486302F135B42 |
ripekg:registry-evidence/RIPEA61C486302F135B42 |
ripe:concerns |
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial |
ripekg:registry-evidence/RIPEA61C486302F135B42 |
ripe:concerns |
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj |
ripekg:registry-evidence/RIPEA61C486302F135B42 |
ripe:isProspective |
true |
ripekg:registry-evidence/RIPEA61C486302F135B42 |
ripe:registrationAssessmentRationale |
Comparison performed at month level. Registration: 2020-05, LLM Recruitment Start: 2020-05. Deemed prospective at month level. |
ripekg:registry-evidence/RIPEA61C486302F135B42 |
ripe:registrationDate |
13-05-2020 |
ripekg:registry-evidence/RIPEA61C486302F135B42 |
ripe:registrationId |
NCT04393194 |
ripekg:registry-evidence/RIPEA61C486302F135B42 |
ripe:registrationLink |
https://clinicaltrials.gov/study/NCT04393194 |
ripekg:registry-evidence/RIPEA61C486302F135B42 |
ripe:registryName |
ClinicalTrials.gov |
ripekg:registry-evidence/RIPEA61C486302F135B42 |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA61C486302F135B42-human-2-2 |
ripekg:registry-evidence/RIPEA61C486302F135B42 |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA61C486302F135B42-inspectai-2-2 |